The aim of this study was to assess the security, value, and efficacy of the second-generation AdVance male sling XP (Boston Scientific®), after implementation in 2010 with advantageous modifications in the sling structure and needle shape, in a prospective multicenter long-term follow-up study.
In total, 115 patients were included. Exclusion criteria were earlier incontinence (UI) surgery, nocturnal UI, former radiotherapy, or night-time incontinence. We also excluded patients with a functional urethra <1 cm in a preoperatively performed repositioning test. A consistent 24-h pad test, International Quality of Life (IQOL) score, visual analog pain scale (VAS), International Consultation-Incontinence Questionnaire (ICIQ-UI SF), International Index of Erectile Function (IIEF-5), International Prostate Symptom Score (IPSS), and Patient Global Impression of Improvement (PGI-I) scores were requested postoperatively.
The 24-month follow-up (114 patients) revealed 64.0% cured and 28.8% improved patients. Mean urine loss was reduced significantly to 19.0 g (p < 0.001). A mean PGI score of 1.5 and a mean VAS score of 0.2 were obtained. The 60-month follow-up (59 patients) revealed 57.6% cured and 25.4% improved patients. Mean urine loss was reduced significantly to 18.3 g (p < 0.001). A mean PGI score of 1.6 and a mean VAS score of 0.2 were obtained.
The AdVance XP displays excellent continence results and secure effectiveness over a 5-year period. Moreover, these data are demonstrating low complication rates and improved quality of life in the long-term use of AdVance XP.
Urologia internationalis. 2021 Jan 29 [Epub ahead of print]
Jan-Niclas Mumm, Benedikt Klehr, Severin Rodler, Alexander Kretschmer, Theresa Vilsmaier, Thilo Westhofen, Michael Chaloupka, Gerald Bastian Schulz, Christian Gozzi, Peter Rehder, Florian May, Roland Homberg, Christian G Stief, Markus Grabbert, Ricarda M Bauer
Department of Urology, University of Munich (LMU), Munich, Germany, ., Department of Urology, University of Munich (LMU), Munich, Germany., Department of Gynecology, University of Munich (LMU), Munich, Germany., Department of Urology, Marienklinik, Bolzano, Italy., Department of Urology, University Hospital Innsbruck, Innsbruck, Austria., Department of Urology, Klinikum Dachau, Dachau, Germany., Department of Urology and Paediatric Urology, St. Barbara Hospital Hamm GmbH, Hamm, Germany., Department of Urology, University Hospital Freiburg, Freiburg, Germany.